Lica Pharma ApS
CVR 46702255 · Private limited company (ApS) · Active · Medium risk
Lica Pharma ApS is a Private limited company (ApS), founded on , based in Hellerup. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 2.6% over the next 12 months, which is 1.9 times the average for Danish companies. CEO: Mark Sonne Kharazmi.
Bankruptcy risk for Lica Pharma ApS
1.9 × the average (1.41%) · higher risk than 86% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 46702255
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (0 years)
- Address
- c/o Kharazmi, Tuborg Havnepark 2, 1. tv
2900 Hellerup - Municipality
- Gentofte
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 20k
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 0 |
| Missing annual report | No |
| Negative equity | – |
| Equity ratio | – |
| Current ratio | – |
| Moves (last 2 years) | 1 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 12 |
| Going-concern uncertainty | No |
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Mark Sonne Kharazmi | Current | |
| Board | Karin Birgitte Sonne Kharazmi | Current | |
| Board | Mark Sonne Kharazmi | Current | |
| Board | Arsalan Kharazmi | Current | |
| Owner (50%) | Karin Birgitte Sonne Kharazmi | Current | |
| Owner (50%) | Arsalan Kharazmi | Current |
The CEOs' other companies
Mark Sonne Kharazmi – 4 other companies, of which 1 bankrupt
- ONESTOPSHOPPING ApS Bankrupt 23 May 2012
- CAZMIC ApS Active
- LICA PHARMACEUTICALS ApS Fusioneret
- NOA IGNITE DENMARK A/S Active
Address history (1 moves)
| c/o Kharazmi, Tuborg Havnepark 2, 1. tv, 2900 Hellerup | |
| c/o Arsalan Kharazmi, Tuborg Havnepark 2, 1. tv, 2900 Hellerup |
Other companies at the same address
- Llebasi Holding IVS Bankrupt
- Llebasi Invest IVS Bankrupt
- Nielsen Advisory IVS Bankrupt
- BEG ApS Active
- BIOSEARCH ApS Fusioneret
- Biosearch Invest ApS Active
- CR EJENDOM ApS Opløst
- EL INVESTERINGSSELSKAB ApS Active
- LICA PHARMACEUTICALS ApS Fusioneret
- LIFE CARE HOLDING ApS Fusioneret
- Reflex Cph. ApS Active
- ÆBELHOLT ApS Active
Similar companies in Gentofte
- SKN computation ApS Gentofte
- WinQure Medicine ApS Klampenborg
- Illum Biotech ApS Charlottenlund
- Novo Nordisk Clinical Innovation Centre A/S Gentofte
- Bollværk ApS Hellerup
- Epitopea ApS Klampenborg
- Spectoceutics ApS Gentofte
- CENEXUM Technologies ApS Gentofte
- Protein Frontiers ApS Gentofte
- ClinOption ApS Dyssegård
- Ascendis Pharma Oncology Division A/S Hellerup
- Merian Life Sciences ApS Hellerup
Questions and answers about Lica Pharma ApS
Has Lica Pharma ApS gone bankrupt?
No, Lica Pharma ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Lica Pharma ApS?
Our model estimates a bankruptcy risk of 2.6% over the next 12 months (medium risk), which is 1.9 times the average for Danish companies.
Who is the CEO of Lica Pharma ApS?
Mark Sonne Kharazmi is the CEO of Lica Pharma ApS.
When was Lica Pharma ApS founded?
Lica Pharma ApS was founded on 17 August 2026.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.